| __timestamp | Novavax, Inc. | Regeneron Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 79435000 | 1271353000 |
| Thursday, January 1, 2015 | 162644000 | 1620577000 |
| Friday, January 1, 2016 | 237939000 | 2052295000 |
| Sunday, January 1, 2017 | 168435000 | 2075142000 |
| Monday, January 1, 2018 | 173797000 | 2186100000 |
| Tuesday, January 1, 2019 | 113842000 | 3036600000 |
| Wednesday, January 1, 2020 | 747027000 | 2735000000 |
| Friday, January 1, 2021 | 2534508000 | 2908100000 |
| Saturday, January 1, 2022 | 1235278000 | 3592500000 |
| Sunday, January 1, 2023 | 737502000 | 4439000000 |
| Monday, January 1, 2024 | 5132000000 |
Unveiling the hidden dimensions of data
In the ever-evolving pharmaceutical industry, innovation is the key to staying ahead. Regeneron Pharmaceuticals, Inc. and Novavax, Inc. have been at the forefront of this race, investing heavily in research and development (R&D) over the past decade. From 2014 to 2023, Regeneron consistently outspent Novavax, with R&D expenses peaking at approximately $4.4 billion in 2023, a 250% increase from 2014. In contrast, Novavax's R&D spending saw a dramatic rise in 2021, reaching its highest at around $2.5 billion, a staggering 3,100% increase from 2014. This surge reflects Novavax's aggressive push in vaccine development, especially during the COVID-19 pandemic. While Regeneron's steady investment underscores its commitment to long-term innovation, Novavax's recent spike highlights its strategic pivot in response to global health challenges. This comparison underscores the diverse strategies companies employ to prioritize innovation in a competitive landscape.
Who Prioritizes Innovation? R&D Spending Compared for AbbVie Inc. and Regeneron Pharmaceuticals, Inc.
Analyzing R&D Budgets: Amgen Inc. vs Novavax, Inc.
Regeneron Pharmaceuticals, Inc. or Teva Pharmaceutical Industries Limited: Who Invests More in Innovation?
Regeneron Pharmaceuticals, Inc. or United Therapeutics Corporation: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for Regeneron Pharmaceuticals, Inc. and Dr. Reddy's Laboratories Limited
Research and Development Investment: Regeneron Pharmaceuticals, Inc. vs Corcept Therapeutics Incorporated
Analyzing R&D Budgets: Regeneron Pharmaceuticals, Inc. vs ADMA Biologics, Inc.
Research and Development Investment: Regeneron Pharmaceuticals, Inc. vs Xenon Pharmaceuticals Inc.
R&D Spending Showdown: Regeneron Pharmaceuticals, Inc. vs Vericel Corporation
Regeneron Pharmaceuticals, Inc. or Taro Pharmaceutical Industries Ltd.: Who Invests More in Innovation?
Research and Development Expenses Breakdown: Halozyme Therapeutics, Inc. vs Novavax, Inc.
R&D Spending Showdown: Verona Pharma plc vs Novavax, Inc.